In vitro studies, Susanti et al. (2013) discovered that ARG treatment of lung adenocarcinoma cells significantly stalled their growth cycle, keeping them predominantly in the GO/G1 phase of the cell cycle and reducing their expression of the NPAT protein. This evidence concerns the gene NPAT and lung adenocarcinoma.